Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017
Presentation Quality-of-life Outcomes After TAVR in an Unselected Population Presenter: Suzanne Arnold February 06, 0017